ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,418,769 | -13.4% | 148,874 | 0.0% | 0.06% | -9.7% |
| Q1 2023 | $1,637,614 | -25.7% | 148,874 | 0.0% | 0.06% | -25.3% |
| Q4 2022 | $2,203,335 | -22.6% | 148,874 | 0.0% | 0.08% | -28.4% |
| Q3 2022 | $2,845,000 | -10.3% | 148,874 | 0.0% | 0.12% | -7.2% |
| Q2 2022 | $3,173,000 | +25.2% | 148,874 | +13.1% | 0.12% | +40.4% |
| Q1 2022 | $2,535,000 | -7.1% | 131,633 | 0.0% | 0.09% | +1.1% |
| Q4 2021 | $2,730,000 | -13.2% | 131,633 | 0.0% | 0.09% | -12.9% |
| Q3 2021 | $3,145,000 | -12.4% | 131,633 | 0.0% | 0.10% | -13.7% |
| Q2 2021 | $3,592,000 | -5.7% | 131,633 | 0.0% | 0.12% | -10.7% |
| Q1 2021 | $3,808,000 | – | 131,633 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |